Abstract:The emergence of avian H7N9 viruses has raised concerns about its pandemic potential and prompted vaccine trials. At present, it is unknown whether there will be sufficient cross-reactive hemagglutinin (HA)-specific CD4 T-cell memory with seasonal influenza to facilitate antibody production to H7 HA. There has also been speculation that H7N9 will have few CD4 T-cell epitopes. In this study, we quantified the potential of seasonal influenza to provide memory CD4 T cells that can cross-reactively recognize H7 HA… Show more
“…Confirmation that this epitope is recognized in human CD4 T cells elicited by seasonal influenza was provided by Kwok and co-workers using HLA-DR1 tetramers (64). We have also obtained strong evidence that CD4 T cells generated by seasonal influenza can cross react with H7-derived peptides (62). In these studies, 17-mer peptides representing the most highly conserved segments of H7 HA relative to its closest seasonal strain (H3) were identified and tested.…”
Section: The Availability Of Ha-specific Cd4 T Cells For Responses Tomentioning
confidence: 96%
“…There is a growing appreciation that vaccine strategies that more fully engage the cellular response can enhance protection. A number of recent studies have sought to quantify and characterize the repertoire of circulating memory CD4 T cells with specificity towards influenza antigens (59, 60, 62, 63, 83–87). Many studies by other groups have concluded that the most prominent influenza-reactive CD4 T cells are those specific for internal virion proteins, particularly M1 and NP (84–86), as well as HA (63).…”
Section: Human Memory Cd4 T Cells Reactive To Influenza Virusmentioning
CD4 T cells convey a number of discrete functions to protective immunity to influenza, a complexity that distinguishes this arm of adaptive immunity from B cells and CD8 T cells. Although the most well recognized function of CD4 T cells is provision of help for antibody production, CD4 T cells are important in many aspects of protective immunity. Our studies have revealed that viral antigen specificity is a key determinant of CD4 T cell function, as illustrated both by mouse models of infection and human vaccine responses, a factor whose importance is due at least in part to events in viral antigen handling. We discuss research that has provided insight into the diverse viral epitope specificity of CD4 T cells elicited after infection, how this primary response is modified as CD4 T cells home to the lung, establish memory, and after challenge with a secondary and distinct influenza virus strain. Our studies in human subjects point out the challenges facing vaccine efforts to facilitate responses to novel and avian strains of influenza, as well as strategies that enhance the ability of CD4 T cells to promote protective antibody responses to both seasonal and potentially pandemic strains of influenza.
“…Confirmation that this epitope is recognized in human CD4 T cells elicited by seasonal influenza was provided by Kwok and co-workers using HLA-DR1 tetramers (64). We have also obtained strong evidence that CD4 T cells generated by seasonal influenza can cross react with H7-derived peptides (62). In these studies, 17-mer peptides representing the most highly conserved segments of H7 HA relative to its closest seasonal strain (H3) were identified and tested.…”
Section: The Availability Of Ha-specific Cd4 T Cells For Responses Tomentioning
confidence: 96%
“…There is a growing appreciation that vaccine strategies that more fully engage the cellular response can enhance protection. A number of recent studies have sought to quantify and characterize the repertoire of circulating memory CD4 T cells with specificity towards influenza antigens (59, 60, 62, 63, 83–87). Many studies by other groups have concluded that the most prominent influenza-reactive CD4 T cells are those specific for internal virion proteins, particularly M1 and NP (84–86), as well as HA (63).…”
Section: Human Memory Cd4 T Cells Reactive To Influenza Virusmentioning
CD4 T cells convey a number of discrete functions to protective immunity to influenza, a complexity that distinguishes this arm of adaptive immunity from B cells and CD8 T cells. Although the most well recognized function of CD4 T cells is provision of help for antibody production, CD4 T cells are important in many aspects of protective immunity. Our studies have revealed that viral antigen specificity is a key determinant of CD4 T cell function, as illustrated both by mouse models of infection and human vaccine responses, a factor whose importance is due at least in part to events in viral antigen handling. We discuss research that has provided insight into the diverse viral epitope specificity of CD4 T cells elicited after infection, how this primary response is modified as CD4 T cells home to the lung, establish memory, and after challenge with a secondary and distinct influenza virus strain. Our studies in human subjects point out the challenges facing vaccine efforts to facilitate responses to novel and avian strains of influenza, as well as strategies that enhance the ability of CD4 T cells to promote protective antibody responses to both seasonal and potentially pandemic strains of influenza.
“…We suspect that the major mechanism that underlies poor responses of humans to avian vaccines is simply a low abundance of memory helper CD4 T cells that are recruited into the response. In our studies on CD4 T cell reactivity to H7 HA-derived epitopes in humans that have never encountered H7 avian viruses or vaccines, we have found that cross-reactivity is detectable in many but is of relatively low abundance for most individuals (24). In contrast, memory CD4 T cells specific for seasonal H1N1-and H3N2-derived HA proteins are readily detectable in humans (25,26).…”
Avian influenza viruses remain a significant concern due to their pandemic potential. Vaccine trials have suggested that humans respond poorly to avian influenza vaccines relative to seasonal vaccines. It is important to understand, first, if there is a general deficiency in the ability of avian hemagglutinin (HA) proteins to generate immune responses and, if so, what underlies this defect. This question is of particular interest because it has been suggested that in humans, the poor immunogenicity of H7 vaccines may be due to a paucity of CD4 T cell epitopes. Because of the generally high levels of cross-reactive CD4 T cells in humans, it is not possible to compare the inherent immunogenicities of avian and seasonal HA proteins in an unbiased manner. Here, we empirically examine the epitope diversity and abundance of CD4 T cells elicited by seasonal and avian HA proteins. HLA-DR1 and HLA-DR4 transgenic mice were vaccinated with purified HA proteins, and CD4 T cells to specific epitopes were identified and quantified. These studies revealed that the diversity and abundance of CD4 T cells specific for HA do not segregate on the basis of whether the HA was derived from human seasonal or avian influenza viruses. Therefore, we conclude that failure in responses to avian vaccines in humans is likely due to a lack of cross-reactive CD4 T cell memory perhaps coupled with competition with or suppression of naive, HA-specific CD4 T cells by memory CD4 T cells specific for more highly conserved proteins.
“…A strong correlation between neutralizing antibody responses following TIV vaccination and the expansion of a circulating CD4+ T-cell population with a Tfh-like phenotype has been reported [140,141]. Furthermore, broadly cross-reactive memory CD4+ T cells capable of recognizing antigenic shift variants can be primed by seasonal influenza exposure [142][143][144]. This population of HA-specific CD4+ memory cells may constitute an expanded pool of Tfh to provide cognate help for HAbinding B cells to subsequent immunization.…”
Section: Uiv Targeting Other Viral Proteinsmentioning
Influenza inflicts significant global mortality and morbidity that can be combated by effective immunization. However, the protective efficacy of current vaccines is limited by both the significant antigenic diversity of the viral hemagglutinin protein and the capacity for rapid antigenic change. This necessitates global influenza surveillance efforts, frequent vaccine reformulation and annual readministration. There is, therefore, tremendous interest in the development of novel strategies to elicit broad and durable protection against both seasonal and pandemic infection. This review presents an overview of candidate universal influenza vaccines designed to elicit cross-protective antibody responses to hemagglutinin. In particular, we focus on the potential impact that widespread pre-existing influenza immunity may play upon the design, testing and deployment of universal influenza vaccines.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.